Filing Details

Accession Number:
0001493152-20-023851
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-12-17 17:02:50
Reporting Period:
2019-09-12
Accepted Time:
2020-12-17 17:02:50
Original Submission Date:
2019-09-12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1383492 S Mitchell Levine C/O Oncocyte Corporation
15 Cushing
Irvine CA 92618
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-12 10,000 $2.01 13,495 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price of $2.006 per share represents a weighted average of prices ranging from $2.003 to $2.006 per share. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
  2. This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on September 12, 2019, which erroneously did not combine the shares of common stock acquired by the Reporting Person on September 12, 2019 with the Reporting Person's common stock reported on his Form 4 on July 31, 2018.